At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 46 target
Drug / intervention
washed microbiota transplantation +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Efficacy and Safety of WMT in the Treatment of Diabetic Gastroparesis: A Multicenter, Randomized, Double-blind, Placebo-controlled Study
The Second Hospital of Nanjing Medical University·interventional·Posted Apr 1, 2024·Updated Sep 10, 2025
In Brief
A clinical study evaluating washed microbiota transplantation and placebo for Diabetic Gastroparesis. Currently recruiting, targeting 46 participants across 1 site.
Detailed Summary
This is a randomized controlled trial to explore the efficacy and safety of washed microbiota transplantation (WMT) for diabetic gastroparesis (DGP) patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Gastroparesis
CountriesChina
Collaborators--
Timeline
N/ARecruiting
20252026202720282029
First PostedApr 2024
Enrollment StartApr 2024
TodayJul 2026
Primary CompletionJan 2029
Study CompletionJul 2029
First PostedApr 1, 2024
Enrollment StartApr 1, 2024
Primary CompletionJan 1, 2029
Study CompletionJul 1, 2029
TodayJul 1, 2026
Enrollment to primary: 4.8 yearsPosted 2.3 years agoPrimary completion in 2.5 years
Interventions
washed microbiota transplantationother
Washed microbiota transplantation refers to the infusion of washed microbiota from healthy donor into patients' gastrointestinal tract. Participants will receive two doses of WMT for DGP.
placeboother
A carrier fluid with matching volume and consistent appearance to the infusion of washed microbiota.